Progenitor cells in arteriosclerosis: Good or bad guys?

Antioxidants and Redox Signaling

Volumn 15, Issue 4, 2011, Pages 1013-1027

  Campagnolo, Paola ^a   Wong, Mei Mei ^a   Xu, Qingbo ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN; PLATELET DERIVED GROWTH FACTOR; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR; VASCULOTROPIN RECEPTOR 2;

ADIPOSE TISSUE; ARTERIOSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL WALL; BONE MARROW CELL; CELL POPULATION; ENDOTHELIAL PROGENITOR CELL; HEART; HUMAN; NEOINTIMA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RESTENOSIS; REVIEW; SMOOTH MUSCLE FIBER; STEM CELL;

ANIMALS; ARTERIOSCLEROSIS; BONE MARROW CELLS; ENDOTHELIAL CELLS; HUMANS; HYPERPLASIA; MICE; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA; NEOVASCULARIZATION, PATHOLOGIC; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 79960417633     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2010.3506     Document Type: Review

References (163)

1. Abedin M, Tintut Y, and Demer LL. Mesenchymal stem cells and the artery wall. Circ Res 95: 671-676, 2004. (Pubitemid 39331926)
2. Adam PJ, Regan CP, Hautmann MB, and Owens GK. Positive-and negative-acting kruppel-like transcription factors bind a transforming growth factor beta control element required for expression of the smooth muscle cell differentiation marker SM22alpha in vivo. J Biol Chem 275: 37798-37806, 2000. (Pubitemid 32004896)
3. Adams B, Xiao Q, and Xu Q. Stem cell therapy for vascular disease. Trends Cardiovasc Med 17: 246-251, 2007. (Pubitemid 47532730)
4. Aicher A, Zeiher AM, and Dimmeler S. Mobilizing endothelial progenitor cells. Hypertension 45: 321-325, 2005. (Pubitemid 40315795)
5. Aoki J, Serruys PW, van Beusekom H, Ong AT, McFadden EP, Sianos G, van der Giessen WJ, Regar E, de Feyter PJ, Davis HR, Rowland S, and Kutryk MJ. Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry. J Am Coll Cardiol 45: 1574-1579, 2005. (Pubitemid 40704488)
6. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, and Isner JM. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85: 221-228, 1999. (Pubitemid 29377293)
7. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, and Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-966, 1997.
8. Bai X, Wang X, and Xu Q. Endothelial damage and stem cell repair in atherosclerosis. Vasc Pharmacol 52: 224-229, 2010.
9. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, Kasahara H, Rota M, Musso E, Urbanek K, Leri A, Kajstura J, Nadal-Ginard B, and Anversa P. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114: 763-776, 2003. (Pubitemid 37186770)
10. Beltrami AP, Cesselli D, Bergamin N, Marcon P, Rigo S, Puppato E, D'Aurizio F, Verardo R, Piazza S, Pignatelli A, Poz A, Baccarani U, Damiani D, Fanin R, Mariuzzi L, Finato N, Masolini P, Burelli S, Belluzzi O, Schneider C, and Beltrami CA. Multipotent cells can be generated in vitro from several adult human organs (heart, liver, and bone marrow). Blood 110: 3438-3446, 2007. (Pubitemid 350106340)
11. Benditt EP and Benditt JM. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci USA 70: 1753-1756, 1973.
12. Bentzon JF, Sondergaard CS, Kassem M, and Falk E. Smooth muscle cells healing atherosclerotic plaque disruptions are of local, not blood, origin in apolipoprotein E knockout mice. Circulation 116: 2053-2061, 2007. (Pubitemid 350023751)
13. Bentzon JF, Weile C, Sondergaard CS, Hindkjaer J, Kassem M, and Falk E. Smooth muscle cells in atherosclerosis originate from the local vessel wall and not circulating progenitor cells in ApoE knockout mice. Arterioscler Thromb Vasc Biol 26: 2696-2702, 2006.
14. Bloch W, Forsberg E, Lentini S, Brakebusch C, Martin K, Krell HW, Weidle UH, Addicks K, and Fassler R. Beta integrin is essential for teratoma growth and angiogenesis. J Cell Biol 139: 265-278, 1997. (Pubitemid 27444097)
15. Bollerot K, Pouget C, and Jaffredo T. The embryonic origins of hematopoietic stem cells: a tale of hemangioblast and hemogenic endothelium. APMIS 113: 790-803, 2005. (Pubitemid 43934221)
16. Bouvard D, Brakebusch C, Gustafsson E, Aszodi A, Bengtsson T, Berna A, and Fassler R. Functional consequences of integrin gene mutations in mice. Circ Res 89: 211-223, 2001. (Pubitemid 34132680)
17. Britten MB, Abolmaali ND, Assmus B, Lehmann R, Honold J, Schmitt J, Vogl TJ, Martin H, Schachinger V, Dimmeler S, and Zeiher AM. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 108: 2212-2218, 2003. (Pubitemid 37368893)
18. Campagnolo P, Cesselli D, Al Haj Zen A, Beltrami AP, Krankel N, Katare R, Angelini G, Emanueli C, and Madeddu P. Human adult vena saphena contains perivascular progenitor cells endowed with clonogenic and proangiogenic potential. Circulation 121: 1735-1745, 2010.
19. Campbell JH, Han CL, and Campbell GR. Neointimal formation by circulating bone marrow cells. Ann N Y Acad Sci 947: 18-24; discussion 24-15, 2001.
20. Caplice NM, Bunch TJ, Stalboerger PG, Wang S, Simper D, Miller DV, Russell SJ, Litzow MR, and Edwards WD. Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc Natl Acad Sci USA 100: 4754-4759, 2003. (Pubitemid 36457802)
21. Carmeliet P. Developmental biology: one cell, two fates. Nature 408: 43, 45, 2000.
22. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, and Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 5, 1996.
23. Covas DT, Panepucci RA, Fontes AM, Silva Jr WA, Orellana MD, Freitas MCC, Neder L, Santos ARD, Peres LC, Jamur MC, and Zago MA. Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146\+ perivascular cells and fibroblasts. Exp Hematol 36: 642-654, 2008.
24. Csiszar A, Labinskyy N, Smith KE, Rivera A, Bakker ENTP, Jo H, Gardner J, Orosz Z, and Ungvari Z. Downregulation of bone morphogenetic protein 4 expression in coronary arterial endothelial cells: role of shear stress and the cAMP=protein kinase A pathway. Arterioscler Thromb Vasc Biol 27: 776-782, 2007. (Pubitemid 46606706)
25. Daub K, Langer H, Seizer P, Stellos K, May AE, Goyal P, Bigalke B, Schonberger T, Geisler T, Siegel-Axel D, Oostendorp RA, Lindemann S, and Gawaz M. Platelets induce differentiation of human CD34\+ progenitor cells into foam cells and endothelial cells. FASEB J 20: 2559-2561, 2006.
26. Davies MG and Hagen PO. Pathobiology of intimal hyperplasia. Br J Surg 81: 1254-1269, 1994. (Pubitemid 24275140)
27. Davies WR, Wang S, Oi K, Bailey KR, Tazelaar HD, Caplice NM, and McGregor CG. Cyclosporine decreases vascular progenitor cell numbers after cardiac transplantation and attenuates progenitor cell growth in vitro. J Heart Lung Transplant 24: 1868-1877, 2005. (Pubitemid 41641864)
28. Deng CX, Wynshaw-Boris A, Shen MM, Daugherty C, Ornitz DM, and Leder P. Murine FGFR-1 is required for early postimplantation growth and axial organization. Genes Dev 8: 3045-3057, 1994.
29. Dimmeler S and Zeiher AM. Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis? J Mol Med 82: 671-677, 2004. (Pubitemid 39468491)
30. Dixelius J, Jakobsson L, Genersch E, Bohman S, Ekblom P, and Claesson-Welsh L. Laminin-1 promotes angiogenesis in synergy with fibroblast growth factor by distinct regulation of the gene and protein expression profile in endothelial cells. J Biol Chem 279: 23766-23772, 2004. (Pubitemid 38685693)
31. Dono R, Texido G, Dussel R, Ehmke H, and Zeller R. Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient mice. EMBO J 17: 4213-4225, 1998. (Pubitemid 28362612)
32. Elsheikh E, Uzunel M, He Z, Holgersson J, Nowak G, and Sumitran-Holgersson S. Only a specific subset of human peripheral-blood monocytes has endothelial-like functional capacity. Blood 106: 2347-2355, 2005. (Pubitemid 41510806)
33. Feng Y, Jacobs F, Van Craeyveld E, Brunaud C, Snoeys J, Tjwa M, Van Linthout S, and De Geest B. Human apoA-I transfer attenuates transplant arteriosclerosis via enhanced incorporation of bone marrow derived endothelial progenitor cells. Arterioscler Thromb Vasc Biol 28: 278-283, 2008. (Pubitemid 351161200)
34. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, and Moore MW. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380: 439-442, 1996. (Pubitemid 26102720)
35. Foteinos G, Hu Y, Xiao Q, Metzler B, and Xu Q. Rapid endothelial turnover in atherosclerosis-prone areas coincides with stem cell repair in apolipoprotein E-deficient mice. Circulation 117: 1856-1863, 2008. (Pubitemid 351507474)
36. Francis SE, Goh KL, Hodivala-Dilke K, Bader BL, Stark M, Davidson D, and Hynes RO. Central roles of {alpha}5{beta} 1 integrin and fibronectin in vascular development in mouse embryos and embryoid bodies. Arterioscler Thromb Vasc Biol 22: 927-933, 2002. (Pubitemid 34655219)
37. Gadue P, Huber TL, Paddison PJ, and Keller GM. Wnt and TGF-beta signaling are required for the induction of an in vitro model of primitive streak formation using embryonic stem cells. Proc Natl Acad Sci USA 103: 16806-16811, 2006. (Pubitemid 44737334)
38. George J, Afek A, Abashidze A, Shmilovich H, Deutsch V, Kopolovich J, Miller H, and Keren G. Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 25: 2636-2641, 2005. (Pubitemid 43732290)
39. Gerritsen ME. Functional heterogeneity of vascular endothelial cells. Biochem Pharmacol 36: 2701-2711, 1987. (Pubitemid 17135870)
40. Gimbrone MA Jr, Topper JN, Nagel T, Anderson KR, and Garcia-Cardena G. Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann N Y Acad Sci 902: 230-239, 2000.
41. Glaser R, Lu MM, Narula N, and Epstein JA. Smooth muscle cells, but not myocytes, of host origin in transplanted human hearts. Circulation 106: 17-19, 2002. (Pubitemid 34747435)
42. Grimm PC, Nickerson P, Jeffery J, Savani RC, Gough J, McKenna RM, Stern E, and Rush DN. Neointimal and tubulointerstitial infiltration by recipient mesenchymal cells in chronic renal-allograft rejection. N Engl J Med 345: 93-97, 2001. (Pubitemid 32634567)
43. Gulati R, Jevremovic D, Peterson TE, Chatterjee S, Shah V, Vile RG, and Simari RD. Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ Res 93: 1023-1025, 2003. (Pubitemid 37485031)
44. Hagensen MK, Shim J, Thim T, Falk E, and Bentzon JF. Circulating endothelial progenitor cells do not contribute to plaque endothelium in murine atherosclerosis. Circulation 121: 898-905, 2006.
45. Han CI, Campbell GR, and Campbell JH. Circulating bone marrow cells can contribute to neointimal formation. J Vasc Res 38: 113-119, 2001. (Pubitemid 32337213)
46. Harraz M, Jiao C, Hanlon HD, Hartley RS, and Schatteman GC. CD34-blood-derived human endothelial cell progenitors. Stem Cells 19: 304-312, 2001. (Pubitemid 32721097)
47. Hautmann MB, Madsen CS, and Owens GK. A transforming growth factor beta (TGFbeta) control element drives TGFbeta-induced stimulation of smooth muscle alpha-actin gene expression in concert with two CArG elements. J Biol Chem 272: 10948-10956, 1997.
48. Hibbert B, Chen YX, and O'Brien ER. c-kit-Immunopositive vascular progenitor cells populate human coronary in-stent restenosis but not primary atherosclerotic lesions. Am J Physiol Heart Circ Physiol 287: H518-H524, 2004. (Pubitemid 38955279)
49. Hill KL, Obrtlikova P, Alvarez DF, King JA, Keirstead SA, Allred JR, and Kaufman DS. Human embryonic stem cellderived vascular progenitor cells capable of endothelial and smooth muscle cell function. Exp Hematol 38: 246-257, 2010.
50. Hillebrands JL, Klatter FA, van den Hurk BM, Popa ER, Nieuwenhuis P, and Rozing J. Origin of neointimal endothelium and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis. J Clin Invest 107: 1411-1422, 2001. (Pubitemid 32522035)
51. Hiratsuka S, Minowa O, Kuno J, Noda T, and Shibuya M. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc Natl Acad Sci USA 95: 9349-9354, 1998. (Pubitemid 28506234)
52. Hirschi KK and Majesky MW. Smooth muscle stem cells. Anat Rec A Discov Mol Cell Evol Biol 276: 22-33, 2004. (Pubitemid 38063875)
53. Hristov M, Zernecke A, Bidzhekov K, Liehn EA, Shagdarsuren E, Ludwig A, and Weber C. Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury. Circ Res 100: 590-597, 2007. (Pubitemid 46673269)
54. Hruban RH, Long PP, Perlman EJ, Hutchins GM, Baumgartner WA, Baughman KL, and Griffin CA. Fluorescence in situ hybridization for the Y-chromosome can be used to detect cells of recipient origin in allografted hearts following cardiac transplantation. Am J Pathol 142: 975-980, 1993. (Pubitemid 24060572)
55. Hu Y, Davison F, Ludewig B, Erdel M, Mayr M, Url M, Dietrich H, and Xu Q. Smooth muscle cells in transplant atherosclerotic lesions are originated from recipients, but not bone marrow progenitor cells. Circulation 106: 1834-1839, 2002.
56. Hu Y, Davison F, Zhang Z, and Xu Q. Endothelial replacement and angiogenesis in arteriosclerotic lesions of allografts are contributed by circulating progenitor cells. Circulation 108: 3122-3127, 2003. (Pubitemid 38031802)
57. Hu Y, Mayr M, Metzler B, Erdel M, Davison F, and Xu Q. Both donor and recipient origins of smooth muscle cells in vein graft atherosclerotic lesions. Circ Res 91: e13-e20, 2002.
58. Hu Y, Zhang Z, Torsney E, Afzal AR, Davison F, Metzler B, and Xu Q. Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice. J Clin Invest 113: 1258-1265, 2004. (Pubitemid 39069924)
59. Hungerford JE and Little CD. Developmental biology of the vascular smooth muscle cell: building a multilayered vessel wall. J Vasc Res 36: 2-27, 1999. (Pubitemid 29106803)
60. Ingram DA, Mead LE, Moore DB, Woodard W, Fenoglio A, and Yoder MC. Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood 105: 2783-2786, 2005. (Pubitemid 40446270)
61. Jarriault S, Brou C, Logeat F, Schroeter EH, Kopan R, and Israel A. Signalling downstream of activated mammalian Notch. Nature 377: 4, 1995.
62. Kalka C, Masuda H, Takahashi T, Gordon R, Tepper O, Gravereaux E, Pieczek A, Iwaguro H, Hayashi S-I, Isner JM, and Asahara T. Vascular endothelial growth factor165 gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res 86: 1198-1202, 2000. (Pubitemid 30436658)
63. Kalka C, Masuda H, Takahashi T, Kalka-Moll WM, Silver M, Kearney M, Li T, Isner JM, and Asahara T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 97: 3422-3427, 2000. (Pubitemid 30183318)
64. Kawamoto A, Gwon H-C, Iwaguro H, Yamaguchi J-I, Uchida S, Masuda H, Silver M, Ma H, Kearney M, Isner JM, and Asahara T. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103: 634-637, 2001. (Pubitemid 32144189)
65. Kawamoto A and Losordo DW. Endothelial progenitor cells for cardiovascular regeneration. Trends Cardiovasc Med 18: 33-37, 2008.
66. Klein D, Hohn HP, Kleff V, Tilki D, and Ergun S. Vascular wall-resident stem cells. Histol Histopathol 25: 681-689, 2005.
67. Klint P, Kanda S, Kloog Y, and Claesson-Welsh L. Contribution of Src and Ras pathways in FGF-2 induced endothelial cell differentiation. Oncogene 18: 3354-3364, 1999. (Pubitemid 29286981)
68. Kumar AHS, Metharom P, Schmeckpeper J, Weiss S, Martin K, and Caplice NM. Bone marrow-derived CX3CR1 progenitors contribute to neointimal smooth muscle cells via fractalkine CX3CR1 interaction. FASEB J 24: 81-92, 2010.
69. Kurpinski K, Lam H, Chu J, Wang A, Kim A, Tsay E, Agrawal S, Schaffer D, and Li S. TGF-beta and notch signaling mediate stem cell differentiation into smooth muscle cells. Stem Cells 28:734-742, 2010.
70. Lawson ND, Scheer N, Pham VN, Kim C-H, Chitnis AB, Campos-Ortega JA, and Weinstein BM. Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development 128: 3675-3683, 2001. (Pubitemid 32998917)
71. Lawson ND, Vogel AM, and Weinstein BM. Sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation. Dev Cell 3: 127-136, 2002. (Pubitemid 34778401)
72. Le Ricousse-Roussanne S, Barateau Vr, Contreres J-o, Boval B, Kraus-Berthier L, and Tobelem G. Ex vivo differentiated endothelial and smooth muscle cells from human cord blood progenitors home to the angiogenic tumor vasculature. Cardiovasc Res 62: 176-184, 2004. (Pubitemid 38326823)
73. Lei L, Liu D, Huang Y, Jovin I, Shai S-Y, Kyriakides T, Ross RS, and Giordano FJ. Endothelial expression of 1 integrin is required for embryonic vascular patterning and postnatal vascular remodeling. Mol Cell Biol 28: 794-802, 2008.
74. Li J, Han X, Jiang J, Zhong R, Williams GM, Pickering JG, and Chow LH. Vascular smooth muscle cells of recipient origin mediate intimal expansion after aortic allotransplantation in mice. Am J Pathol 158: 1943-1947, 2001. (Pubitemid 32545177)
75. Lin Y WD, Solovey A, and Hebbel RP. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 105: 7, 2000.
76. Liu P, Zhou B, Gu D, Zhang L, and Han Z. Endothelial progenitor cell therapy in atherosclerosis: a double-edged sword? Ageing Res Rev 8: 83-93, 2009.
77. Liu Y, Sinha S, and Owens G. A transforming growth factor-beta control element required for SM alpha-actin expression in vivo also partially mediates GKLF-dependent transcriptional repression. J Biol Chem 278: 48004-48011, 2003. (Pubitemid 37523250)
78. Logan CY and Nusse R. The Wnt signalling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781-810, 2004. (Pubitemid 39488658)
79. Losordo DW and Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies. Circulation 109: 2692-2697, 2004. (Pubitemid 38737912)
80. Losordo DW and Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease: part I: angiogenic cytokines. Circulation 109: 2487-2491, 2004. (Pubitemid 38720544)
81. Majesky MW. Developmental basis of vascular smooth muscle diversity. Arterioscler Thromb Vasc Biol 27: 1248-1258, 2007. (Pubitemid 46809412)
82. Malan D, Wenzel D, Schmidt A, Geisen C, Raible A, BHqlck B, Fleischmann BK, and Bloch W. Endothelial beta1 integrins regulate sprouting and network formation during vascular development. Development 137: 993-1002, 2010.
83. Margariti A XQ, Zampetaki A, Hu Y, Zeng L, Xu Q. HDAC7 is essential for stem cell differentiation into smooth muscle cells. Circulation 116: II-71, 2007.
84. Margariti A, Zeng L, and Xu Q. Stem cells, vascular smooth muscle cells and atherosclerosis. Histol Histopathol 21: 979-985, 2006. (Pubitemid 44082741)
85. Marsboom G and Janssens S. Endothelial progenitor cells: new perspectives and applications in cardiovascular therapies. Expert Rev Cardiovasc Ther 6: 687-701, 2008.
86. Masumura T, Yamamoto K, Shimizu N, Obi S, and Ando J. Shear stress increases expression of the arterial endothelial marker EphrinB2 in murine ES cells via the VEGF-Notch signaling pathways. Arterioscler Thromb Vasc Biol 29: 2125-2131, 2009.
87. Mayr M, Li C, Zou Y, Huemer U, Hu Y, and Xu Q. Biomechanical stress-induced apoptosis in vein grafts involves p38 mitogen-activated protein kinases. FASEB J 14: 261-270, 2000. (Pubitemid 30086063)
88. Meirelles LdS, Caplan AI, and Nardi NB. In search of the in vivo identity of mesenchymal stem cells. Stem Cells 26: 2287-2299, 2008.
89. Metharom P, Kumar AHS, Weiss S, and Caplice NM. A specific subset of mouse bone marrow cells has smooth muscle cell differentiation capacity. Arterioscler Thromb Vasc Biol 30: 533-535, 2010.
90. Minami E, Laflamme MA, Saffitz JE, and Murry CE. Extracardiac progenitor cells repopulate most major cell types in the transplanted human heart. Circulation 112: 2951-2958, 2005. (Pubitemid 41612297)
91. Miquerol L, Langille BL, and Nagy A. Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. Development 127: 6, 2000.
92. Miranville A HC, Sengenès C, Curat CA, Busse R, Bouloumie ́ A. Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation 110: 7, 2004.
93. Miyata T, Iizasa H, Sai Y, Fujii J, Terasaki T, and Nakashima E. Platelet-derived growth factor-BB (PDGF-BB) induces differentiation of bone marrow endothelial progenitor cell-derived cell line TR-BME2 into mural cells, and changes the phenotype. J Cell Physiol 204: 948-955, 2005. (Pubitemid 41099281)
94. Moon MH KS, Kim YJ, Kim SJ, Lee JB, Bae YC, Sung SM, and Jung JS. Human adipose tissue-derived mesenchymal stem cells improve postnatal neovascularization in a mouse model of hindlimb ischemia. Cell Physiol Biochem 17: 12, 2006.
95. Mottet D, Bellahcene A, Pirotte S, Waltregny D, Deroanne C, Lamour V, Lidereau R, and Castronovo V. Histone deacetylase 7 silencing alters endothelial cell migration, a key step in angiogenesis. Circ Res 101: 1237-1246, 2007. (Pubitemid 350294640)
96. Moulton KS. Plaque angiogenesis and atherosclerosis. Curr Atheroscler Rep 3: 225-233, 2001.
97. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MAS, and Rafii S. Expression of VEGFR-2 and AC133 by circulating human CD34\+ cells identifies a population of functional endothelial precursors. Blood 95: 952-958, 2000. (Pubitemid 30062717)
98. Pepe AE, Xiao Q, Zampetaki A, Zhang Z, Kobayashi A, Hu Y, and Xu Q. Crucial role of nrf3 in smooth muscle cell differentiation from stem cells. Circ Res 106: 870-879, 2010.
99. Porretti L, Cattaneo A, Colombo F, Lopa R, Rossi G, Mazzaferro V, Battiston C, Svegliati-Baroni G, Bertolini F, Rebulla P, and Prati D. Simultaneous characterization of progenitor cell compartments in adult human liver. Cytometry 77A: 31-40, 2010.
100. Pozzi A and Zent R. Integrins: sensors of extracellular matrix and modulators of cell function. Nephron Exp Nephrol 94: e77-e84, 2003.
101. Pula G, Mayr U, Evans C, Prokopi M, Vara DS, Yin X, Astroulakis Z, Xiao Q, Hill J, Xu Q, and Mayr M. Proteomics identifies thymidine phosphorylase as a key regulator of the angiogenic potential of colony-forming units and endothelial progenitor cell cultures. Circ Res 104: 32-40, 2009.
102. Quaini F, Urbanek K, Beltrami AP, Finato N, Beltrami CA, Nadal-Ginard B, Kajstura J, Leri A, and Anversa P. Chimerism of the transplanted heart. N Engl J Med 346: 5-15, 2002. (Pubitemid 34438914)
103. Rabelink TJ, de Boer HC, de Koning EJP, and van Zonneveld A-J. Endothelial progenitor cells: more than an inflammatory response? Arterioscler Thromb Vasc Biol 24: 834-838, 2004. (Pubitemid 38620859)
104. Rahmani M, Cruz RP, Granville DJ, and McManus BM. Allograft vasculopathy versus atherosclerosis. Circ Res 99: 801-815, 2006. (Pubitemid 44556379)
105. Rehman J, Li J, Orschell CM, and March KL. Peripheral blood "endothelial progenitor cells" are derived from monocyte=macrophages and secrete angiogenic growth factors. Circulation 107: 1164-1169, 2003. (Pubitemid 36297209)
106. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 340: 115-126, 1999.
107. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med 314: 488-500, 1986.
108. Ross R and Glomset JA. The pathogenesis of atherosclerosis (first of two parts). N Engl J Med 295: 369-377, 1976.
109. Ross R and Glomset JA. The pathogenesis of atherosclerosis (second of two parts). N Engl J Med 295: 420-425, 1976.
110. Rotmans JI, Heyligers JM, Verhagen HJ, Velema E, Nagtegaal MM, de Kleijn DP, de Groot FG, Stroes ES, and Pasterkamp G. In vivo cell seeding with anti-CD34 antibodies successfully accelerates endothelialization but stimulates intimal hyperplasia in porcine arteriovenous expanded polytetrafluoroethylene grafts. Circulation 112: 12-18, 2005. (Pubitemid 40962563)
111. Sainz J, Al Haj Zen A, Caligiuri G, Demerens C, Urbain D, Lemitre M, and Lafont A. Isolation of "side population" progenitor cells from healthy arteries of adult mice. Arterioscler Thromb Vasc Biol 26: 281-286, 2006. (Pubitemid 43732188)
112. Saiura A, Sata M, Hirata Y, Nagai R, and Makuuchi M. Circulating smooth muscle progenitor cells contribute to atherosclerosis. Nat Med 7: 382-383, 2001. (Pubitemid 32298513)
113. Sase H, Watabe T, Kawasaki K, Miyazono K, and Miyazawa K. VEGFR2-PLC{gamma}1 axis is essential for endothelial specification of VEGFR2\+ vascular progenitor cells. J Cell Sci 122: 3303-3311, 2009.
114. Sata M. Circulating vascular progenitor cells contribute to vascular repair, remodeling, and lesion formation. Trends Cardiovasc Med 13: 249-253, 2003. (Pubitemid 36960173)
115. Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T, Hirai H, Makuuchi M, Hirata Y, and Nagai R. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 8: 403-409, 2002. (Pubitemid 34407037)
116. Schnittler HJ. Structural and functional aspects of intercellular junctions in vascular endothelium. Basic Res Cardiol 93 suppl 3: 30-39, 1998.
117. Schroeter MR, Humboldt T, Schafer K, and Konstantinides S. Rosuvastatin reduces atherosclerotic lesions and promotes progenitor cell mobilisation and recruitment in apolipoprotein E knockout mice. Atherosclerosis 205: 63-73, 2009.
118. Schwartz SM and Benditt EP. Aortic endothelial cell replication, I: effects of age and hypertension in the rat. Circ Res 41: 248-255, 1977. (Pubitemid 8138734)
119. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu X-F, Breitman ML, and Schuh AC. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62-66, 1995.
120. Shawber CJ and Kitajewski J. Notch function in the vasculature: insights from zebrafish, mouse and man. BioEssays 26: 225-234, 2004. (Pubitemid 38325664)
121. Shimizu K, Sugiyama S, Aikawa M, Fukumoto Y, Rabkin E, Libby P, and Mitchell RN. Host bone-marrow cells are a source of donor intimal smooth-muscle-like cells in murine aortic transplant arteriopathy. Nat Med 7: 738-741, 2001. (Pubitemid 32588032)
122. Simper D, Mayr U, Urbich C, Zampetaki A, Prokopi M, Didangelos A, Saje A, Mueller M, Benbow U, Newby A, Apweiler R, Rahman S, Dimmeler S, Xu Q, and Mayr M. Comparative proteomics profiling reveals pole of smooth muscle progenitors in extracellular matrix production. Arterioscler Thromb Vasc Biol 30:1325-1332, 2010.
123. Simper D, Stalboerger PG, Panetta CJ, Wang S, and Caplice NM. Smooth muscle progenitor cells in human blood. Circulation 106: 1199-1204, 2002. (Pubitemid 34988636)
124. Simper D, Wang S, Deb A, Holmes D, McGregor C, Frantz R, Kushwaha SS, and Caplice NM. Endothelial progenitor cells are decreased in blood of cardiac allograft patients with vasculopathy and endothelial cells of noncardiac origin are enriched in transplant atherosclerosis. Circulation 108: 143-149, 2003. (Pubitemid 36871294)
125. Stary HC. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis 9: I19-132, 1989.
126. Stellos K, Langer H, Daub K, Schoenberger T, Gauss A, Geisler T, Bigalke B, Mueller I, Schumm M, Schaefer I, Seizer P, Kraemer BF, Siegel-Axel D, May AE, Lindemann S, and Gawaz M. Platelet-derived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34\+ cells to endothelial progenitor cells. Circulation 117: 206-215, 2008.
127. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, and Asahara T. Ischemiaand cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5: 434-438, 1999. (Pubitemid 29180584)
128. Tanaka K, Sata M, Hirata Y, and Nagai R. Diverse contribution of bone marrow cells to neointimal hyperplasia after mechanical vascular injuries. Circ Res 93: 783-790, 2003. (Pubitemid 37288674)
129. Timmermans F, Plum J, Yider MC, Ingram DA, Vandekerckhove B, and Case J. Endothelial progenitor cells: identity defined? J Cell Mol Med 13: 87-102, 2009.
130. Traktuev DO, Merfeld-Clauss S, Li J, Kolonin M, Arap W, Pasqualini R, Johnstone BH, and March KL. A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circ Res 102: 77-85, 2008.
131. Urbich C and Dimmeler S. Endothelial progenitor cells functional characterization. Trends Cardiovasc Med 14: 318-322, 2004. (Pubitemid 41110611)
132. Urbich C and Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 95: 343-353, 2004. (Pubitemid 39100452)
133. Venneri MA, Palma MD, Ponzoni M, Pucci F, Scielzo C, Zonari E, Mazzieri R, Doglioni C, and Naldini L. Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer. Blood 109: 5276-5285, 2007. (Pubitemid 46890548)
134. Wang C-H, Cherng W-J, Yang N-I, Kuo L-T, Hsu C-M, Yeh H-I, Lan Y-J, Yeh C-H, and Stanford WL. Late-outgrowth endothelial cells attenuate intimal hyperplasia contributed by mesenchymal stem cells after vascular injury. Arterioscler Thromb Vasc Biol 28: 54-60, 2008.
135. Wang H, Riha GM, Yan S, Li M, Chai H, Yang H, Yao Q, and Chen C. Shear stress induces endothelial differentiation from a murine embryonic mesenchymal progenitor cell line. Arterioscler Thromb Vasc Biol 25: 1817-1823, 2005. (Pubitemid 41243448)
136. Wassmann S, Werner N, Czech T, and Nickenig G. Improvement of endothelial function by systemic transfusion of vascular progenitor cells. Circ Res 99: e74-e83, 2006. (Pubitemid 44556373)
137. Weis M and von Scheidt W. Cardiac allograft vasculopathy: a review. Circulation 96: 2069-2077, 1997. (Pubitemid 27400772)
138. Werner N, Junk S, Laufs U, Link A, Walenta K, Bohm M, and Nickenig G. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 93: e17-e24, 2003.
139. Woll PS, Morris JK, Painschab MS, Marcus RK, Kohn AD, Biechele TL, Moon RT, and Kaufman DS. Wnt signaling promotes hematoendothelial cell development from human embryonic stem cells. Blood 111: 122-131, 2008.
140. Xiao Q, Luo Z, Pepe AE, Margariti A, Zeng L, and Xu Q. Embryonic stem cell differentiation into smooth muscle cells is mediated by Nox4-produced H2O2. Am J Physiol Cell Physiol 296: C711-C723, 2009.
141. XiaoQ RN, Jahangiri M, Xu Q. Stem cells, progenitor cells and vascular diseases. In Stem Cell Research and Devopment, edited by Fong CA. New York: NOVA Science Publishers; 2007.pp 5-54
142. Xiao Q, Zeng L, Zhang Z, Hu Y, and Xu Q. Stem cellderived Sca-1\+ progenitors differentiate into smooth muscle cells, which is mediated by collagen IV-integrin alpha1=beta1=alphav and PDGF receptor pathways. Am J Physiol Cell Physiol 292: C342-C352, 2007. (Pubitemid 46127310)
143. Xiao Q, Zeng L, Zhang Z, Margariti A, Ali ZA, Channon KM, Xu Q, and Hu Y. Sca-1\+ progenitors derived from embryonic stem cells differentiate into
144. Xiong JW. Molecular and developmental biology of the hemangioblast. Dev Dyn 237: 1218-1231, 2008.
145. Xu C, Lee S, Singh TM, Sho E, Li X, Sho M, Masuda H, and Zarins CK. Molecular mechanisms of aortic wall remodeling in response to hypertension. J Vasc Surg 33: 570-578, 2001. (Pubitemid 32215608)
146. Xu J, Liu X, Jiang Y, Chu L, Hao H, Liua Z, Verfaillie C, Zweier J, Gupta K, and Liu Z. MAPK=ERK signalling mediates VEGF-induced bone marrow stem cell differentiation into endothelial cell. J Cell Mol Med 12: 2395-2406, 2008.
147. Xu Q. Mouse models of arteriosclerosis: from arterial injuries to vascular grafts. Am J Pathol 165: 1-10, 2004. (Pubitemid 38821809)
148. Xu Q. Progenitor cells in vascular repair. Curr Opin Lipidol 18: 534-539, 2007. (Pubitemid 47462206)
149. Xu Q. Stem cells and transplant arteriosclerosis. Circ Res 102: 1011-1024, 2008. (Pubitemid 351667855)
150. Xu Q, Zhang Z, Davison F, and Hu Y. Circulating progenitor cells regenerate endothelium of vein graft atherosclerosis, which is diminished in apoE-deficient mice. Circ Res 93: e76-e86, 2003.
151. Xu X, Weinstein M, Li C, Naski M, Cohen RI, Ornitz DM, Leder P, and Deng C. Fibroblast growth factor receptor 2 (FGFR2)-mediated reciprocal regulation loop between FGF8 and FGF10 is essential for limb induction. Development 125: 753-765, 1998. (Pubitemid 28108099)
152. Yamamizu K, Kawasaki K, Katayama S, Watabe T, and Yamashita JK. Enhancement of vascular progenitor potential by protein kinase A through dual induction of Flk-1 and Neuropilin-1. Blood 114: 3707-3716, 2009.
153. Yamamoto K, Sokabe T, Watabe T, Miyazono K, Yamashita JK, Obi S, Ohura N, Matsushita A, Kamiya A, and Ando J. Fluid shear stress induces differentiation of Flk-1-positive embryonic stem cells into vascular endothelial cells in vitro. Am J Physiol Heart Circ Physiol 288: H1915-H1924, 2005. (Pubitemid 40418021)
154. Yamashita J, Itoh H, Hirashima M, Ogawa M, Nishikawa S, Yurugi T, Naito M, and Nakao K. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408: 92-96, 2000.
155. Yang D-H, Yoon J-Y, Lee S-H, Bryja V, Andersson ER, Arenas E, Kwon Y-G, and Choi K-Y. Wnt5a is required for endothelial differentiation of embryonic stem cells and vascularization via pathways involving both Wnt={beta}-catenin and protein kinase C{alpha}. Circ Res 104: 372-379, 2009.
156. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, Krasich R, Temm CJ, Prchal JT, and Ingram DA. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem=progenitor cell principals. Blood 109: 1801-1809, 2007. (Pubitemid 46348173)
157. Yokote K, Take A, Nakaseko C, Kobayashi K, Fujimoto M, Kawamura H, Maezawa Y, Nishimura M, Mori S, and Saito Y. Bone marrow-derived vascular cells in response to injury. J Atheroscler Thromb 10: 205-210, 2003.
158. Zampetaki A, Kirton JP, and Xu Q. Vascular repair by endothelial progenitor cells. Cardiovasc Res 78: 413-421, 2008. (Pubitemid 351769775)
159. Zeng L, Xiao Q, Margariti A, Zhang Z, Zampetaki A, Patel S, Capogrossi MC, Hu Y, and Xu Q. HDAC3 is crucial in shear-and VEGF-induced stem cell differentiation toward endothelial cells. J Cell Biol 174: 1059-1069, 2006. (Pubitemid 44455193)
160. Zeng L, Zampetaki A, Margariti A, Pepe AE, Alam S, Martin D, Xiao Q, Wang W, Jin ZG, Cockerill G, Mori K, Li YS, Hu Y, Chien S, and Xu Q. Sustained activation of XBP1 splicing leads to endothelial apoptosis and atherosclerosis development in response to disturbed flow. Proc Natl Acad Sci USA 106: 8326-8331, 2009.
161. Zengin E, Chalajour F, Gehling UM, Ito WD, Treede H, Lauke H, Weil J, Reichenspurner H, Kilic N, and Ergun S. Vascular wall resident progenitor cells: a source for postnatal vasculogenesis. Development 133: 1543-1551, 2006. (Pubitemid 43732967)
162. Zoll J, Fontaine V, Gourdy P, Barateau V, Vilar J, Leroyer A, Lopes-Kam I, Mallat Z, Arnal JF, Henry P, Tobelem G, and Tedgui A. Role of human smooth muscle cell progenitors in atherosclerotic plaque development and composition. Cardiovasc Res 77: 471-480, 2008. (Pubitemid 351197652)
163. Zou Y, Hu Y, Mayr M, Dietrich H, Wick G, and Xu Q. Reduced neointima hyperplasia of vein bypass grafts in intercellular adhesion molecule-1-deficient mice. Circ Res 86: 434-440, 2000. (Pubitemid 30141762)